Is there any prognostic significance in pleural involvement and/or effusion (Ple-I/E) in patients with ALK-positive NSCLC?

Abstract

44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona, SPAIN, SEP 27-OCT 01, 2019